annual CAPEX:
$44.09M-$10.47M(-19.19%)Summary
- As of today (August 20, 2025), GMAB annual capital expenditures is $44.09 million, with the most recent change of -$10.47 million (-19.19%) on December 31, 2024.
- During the last 3 years, GMAB annual CAPEX has risen by +$4.04 million (+10.08%).
- GMAB annual CAPEX is now -41.65% below its all-time high of $75.56 million, reached on December 31, 2018.
Performance
GMAB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$10.30M-$19.72M(-65.69%)Summary
- As of today (August 20, 2025), GMAB quarterly capital expenditures is $10.30 million, with the most recent change of -$19.72 million (-65.69%) on June 1, 2025.
- Over the past year, GMAB quarterly CAPEX has increased by +$6.41 million (+164.78%).
- GMAB quarterly CAPEX is now -65.69% below its all-time high of $30.02 million, reached on March 31, 2025.
Performance
GMAB quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$76.68M+$6.41M(+9.12%)Summary
- As of today (August 20, 2025), GMAB TTM capital expenditures is $76.68 million, with the most recent change of +$6.41 million (+9.12%) on June 1, 2025.
- Over the past year, GMAB TTM CAPEX has increased by +$45.22 million (+143.74%).
- GMAB TTM CAPEX is now at all-time high.
Performance
GMAB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GMAB CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -19.2% | +164.8% | +143.7% |
3 y3 years | +10.1% | +5.0% | +86.3% |
5 y5 years | +164.9% | -51.6% | +87.1% |
GMAB CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -19.2% | +10.1% | -65.7% | +164.8% | at high | +219.2% |
5 y | 5-year | -19.2% | +164.9% | -65.7% | +164.8% | at high | +219.2% |
alltime | all time | -41.6% | >+9999.0% | -65.7% | +1879.9% | at high | >+9999.0% |
GMAB CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $10.30M(-65.7%) | $76.68M(+9.1%) |
Mar 2025 | - | $30.02M(+2.2%) | $70.27M(+58.5%) |
Dec 2024 | $44.09M(-19.2%) | $29.36M(+319.7%) | $44.33M(+84.5%) |
Sep 2024 | - | $7.00M(+79.9%) | $24.02M(-23.6%) |
Jun 2024 | - | $3.89M(-4.6%) | $31.46M(-27.3%) |
Mar 2024 | - | $4.08M(-55.0%) | $43.28M(-20.1%) |
Dec 2023 | $54.56M(+21.8%) | $9.06M(-37.2%) | $54.20M(-9.6%) |
Sep 2023 | - | $14.44M(-8.1%) | $59.96M(+5.7%) |
Jun 2023 | - | $15.71M(+4.8%) | $56.75M(+11.6%) |
Mar 2023 | - | $14.99M(+1.1%) | $50.85M(+14.4%) |
Dec 2022 | $44.78M(+11.8%) | $14.82M(+32.1%) | $44.45M(+10.9%) |
Sep 2022 | - | $11.22M(+14.4%) | $40.10M(-2.6%) |
Jun 2022 | - | $9.81M(+14.1%) | $41.17M(-6.8%) |
Mar 2022 | - | $8.59M(-17.9%) | $44.15M(+10.1%) |
Dec 2021 | $40.05M(-14.7%) | $10.47M(-14.8%) | $40.09M(+1.6%) |
Sep 2021 | - | $12.30M(-3.9%) | $39.47M(+13.8%) |
Jun 2021 | - | $12.79M(+182.1%) | $34.67M(-19.7%) |
Mar 2021 | - | $4.53M(-53.9%) | $43.15M(-8.5%) |
Dec 2020 | $46.95M(+182.1%) | $9.85M(+31.4%) | $47.17M(+13.9%) |
Sep 2020 | - | $7.50M(-64.8%) | $41.41M(+1.0%) |
Jun 2020 | - | $21.27M(+148.8%) | $40.99M(+87.6%) |
Mar 2020 | - | $8.55M(+109.0%) | $21.84M(+32.1%) |
Dec 2019 | $16.64M(-78.0%) | $4.09M(-42.1%) | $16.54M(+8.1%) |
Sep 2019 | - | $7.07M(+231.6%) | $15.31M(+55.0%) |
Jun 2019 | - | $2.13M(-34.4%) | $9.88M(-8.6%) |
Mar 2019 | - | $3.25M(+13.7%) | $10.80M(-12.2%) |
Dec 2018 | $75.56M(+463.0%) | $2.86M(+74.7%) | $12.30M(-4.5%) |
Sep 2018 | - | $1.64M(-46.5%) | $12.88M(-16.8%) |
Jun 2018 | - | $3.06M(-35.6%) | $15.49M(-12.3%) |
Mar 2018 | - | $4.75M(+37.9%) | $17.66M(+31.2%) |
Dec 2017 | $13.42M(+172.8%) | $3.44M(-18.8%) | $13.46M(-1.6%) |
Sep 2017 | - | $4.24M(-18.8%) | $13.68M(+41.6%) |
Jun 2017 | - | $5.22M(+845.1%) | $9.66M(+97.7%) |
Mar 2017 | - | $552.70K(-84.9%) | $4.89M(-1.1%) |
Dec 2016 | $4.92M(-75.6%) | $3.66M(+1547.1%) | $4.94M(+32.9%) |
Sep 2016 | - | $222.30K(-50.7%) | $3.72M(-5.2%) |
Jun 2016 | - | $450.60K(-25.7%) | $3.92M(-78.1%) |
Mar 2016 | - | $606.50K(-75.1%) | $17.88M(-11.7%) |
Dec 2015 | $20.13M(+49.9%) | $2.44M(+474.4%) | $20.25M(+11.7%) |
Sep 2015 | - | $424.50K(-97.1%) | $18.14M(-39.2%) |
Jun 2015 | - | $14.41M(+383.7%) | $29.84M(+84.8%) |
Mar 2015 | - | $2.98M(+817.7%) | $16.15M(+19.5%) |
Dec 2014 | $13.42M(+627.6%) | $324.60K(-97.3%) | $13.51M(-4.4%) |
Sep 2014 | - | $12.13M(+1581.4%) | $14.13M(+452.3%) |
Jun 2014 | - | $721.20K(+112.8%) | $2.56M(+22.6%) |
Mar 2014 | - | $338.90K(-64.1%) | $2.09M(+13.3%) |
Dec 2013 | $1.85M(+18.8%) | $944.10K(+70.4%) | $1.84M(+10.7%) |
Sep 2013 | - | $554.20K(+122.6%) | $1.66M(+14.6%) |
Jun 2013 | - | $249.00K(+163.2%) | $1.45M(-2.1%) |
Mar 2013 | - | $94.60K(-87.6%) | $1.48M(-4.4%) |
Dec 2012 | $1.55M | $765.90K(+123.7%) | $1.55M(+31.4%) |
Sep 2012 | - | $342.40K(+22.0%) | $1.18M(+9.8%) |
Jun 2012 | - | $280.70K(+72.4%) | $1.08M(-10.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $162.80K(-58.8%) | $1.21M(-11.0%) |
Dec 2011 | $1.34M(-25.0%) | $394.90K(+66.3%) | $1.35M(-19.1%) |
Sep 2011 | - | $237.40K(-42.1%) | $1.67M(-14.8%) |
Jun 2011 | - | $409.90K(+31.3%) | $1.97M(-3.7%) |
Mar 2011 | - | $312.20K(-56.3%) | $2.04M(+13.7%) |
Dec 2010 | $1.79M(-43.0%) | $714.50K(+35.2%) | $1.79M(+5.7%) |
Sep 2010 | - | $528.60K(+9.1%) | $1.70M(-13.7%) |
Jun 2010 | - | $484.70K(+630.0%) | $1.97M(-25.4%) |
Mar 2010 | - | $66.40K(-89.3%) | $2.64M(-16.1%) |
Dec 2009 | $3.15M(-69.9%) | $618.30K(-22.5%) | $3.15M(-51.9%) |
Sep 2009 | - | $798.20K(-30.9%) | $6.54M(-29.9%) |
Jun 2009 | - | $1.16M(+101.6%) | $9.33M(+2.6%) |
Mar 2009 | - | $573.10K(-85.7%) | $9.09M(-13.0%) |
Dec 2008 | $10.45M(+325.3%) | - | - |
Dec 2008 | - | $4.01M(+11.9%) | $10.45M(+26.0%) |
Sep 2008 | - | $3.58M(+291.7%) | $8.30M(+70.1%) |
Jun 2008 | - | $915.10K(-52.7%) | $4.88M(+17.0%) |
Mar 2008 | - | $1.94M(+4.2%) | $4.17M(+69.7%) |
Dec 2007 | $2.46M(+646.9%) | - | - |
Dec 2007 | - | $1.86M(+1011.6%) | $2.46M(+282.6%) |
Sep 2007 | - | $167.20K(-18.8%) | $642.10K(+10.0%) |
Jun 2007 | - | $205.80K(-8.6%) | $583.70K(+23.1%) |
Mar 2007 | - | $225.20K(+413.0%) | $474.30K(+44.2%) |
Dec 2006 | $328.90K(-18.8%) | - | - |
Dec 2006 | - | $43.90K(-59.7%) | $328.90K(-37.9%) |
Sep 2006 | - | $108.80K(+12.9%) | $529.50K(+12.8%) |
Jun 2006 | - | $96.40K(+20.8%) | $469.30K(+1.9%) |
Mar 2006 | - | $79.80K(-67.4%) | $460.70K(+13.8%) |
Dec 2005 | $404.80K(-70.8%) | - | - |
Dec 2005 | - | $244.50K(+403.1%) | $404.80K(-25.1%) |
Sep 2005 | - | $48.60K(-44.6%) | $540.10K(-3.1%) |
Jun 2005 | - | $87.80K(+267.4%) | $557.10K(-42.9%) |
Mar 2005 | - | $23.90K(-93.7%) | $975.20K(-29.7%) |
Dec 2004 | $1.39M(-38.6%) | - | - |
Dec 2004 | - | $379.80K(+479.0%) | $1.39M(+223.9%) |
Sep 2004 | - | $65.60K(-87.0%) | $428.00K(-31.6%) |
Jun 2004 | - | $505.90K(+16.3%) | $625.40K(-39.8%) |
Mar 2004 | - | $435.10K(-175.2%) | $1.04M(-54.0%) |
Dec 2003 | $2.26M(-82.5%) | - | - |
Dec 2003 | - | -$578.60K(-320.0%) | $2.26M(-20.4%) |
Sep 2003 | - | $263.00K(-71.4%) | $2.84M(-45.5%) |
Jun 2003 | - | $918.60K(-44.5%) | $5.20M(+5.0%) |
Mar 2003 | - | $1.65M(-37.0%) | $4.95M(-54.8%) |
Dec 2002 | $12.90M(+102.0%) | - | - |
Sep 2002 | - | $2.63M(+293.0%) | $10.95M(+17.6%) |
Jun 2002 | - | $668.60K(-80.7%) | $9.31M(+5.5%) |
Mar 2002 | - | $3.46M(-17.5%) | $8.83M(+46.7%) |
Dec 2001 | $6.39M(+812.5%) | $4.20M(+325.1%) | $6.02M(+230.7%) |
Sep 2001 | - | $987.00K(+445.3%) | $1.82M(+118.6%) |
Jun 2001 | - | $181.00K(-72.2%) | $832.10K(+27.8%) |
Mar 2001 | - | $651.10K | $651.10K |
Dec 2000 | $699.80K(+877.4%) | - | - |
Dec 1999 | $71.60K | - | - |
FAQ
- What is Genmab A/S annual capital expenditures?
- What is the all time high annual CAPEX for Genmab A/S?
- What is Genmab A/S annual CAPEX year-on-year change?
- What is Genmab A/S quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Genmab A/S?
- What is Genmab A/S quarterly CAPEX year-on-year change?
- What is Genmab A/S TTM capital expenditures?
- What is the all time high TTM CAPEX for Genmab A/S?
- What is Genmab A/S TTM CAPEX year-on-year change?
What is Genmab A/S annual capital expenditures?
The current annual CAPEX of GMAB is $44.09M
What is the all time high annual CAPEX for Genmab A/S?
Genmab A/S all-time high annual capital expenditures is $75.56M
What is Genmab A/S annual CAPEX year-on-year change?
Over the past year, GMAB annual capital expenditures has changed by -$10.47M (-19.19%)
What is Genmab A/S quarterly capital expenditures?
The current quarterly CAPEX of GMAB is $10.30M
What is the all time high quarterly CAPEX for Genmab A/S?
Genmab A/S all-time high quarterly capital expenditures is $30.02M
What is Genmab A/S quarterly CAPEX year-on-year change?
Over the past year, GMAB quarterly capital expenditures has changed by +$6.41M (+164.78%)
What is Genmab A/S TTM capital expenditures?
The current TTM CAPEX of GMAB is $76.68M
What is the all time high TTM CAPEX for Genmab A/S?
Genmab A/S all-time high TTM capital expenditures is $76.68M
What is Genmab A/S TTM CAPEX year-on-year change?
Over the past year, GMAB TTM capital expenditures has changed by +$45.22M (+143.74%)